Literature DB >> 12907395

Simian immunodeficiency virus encephalitis in the white matter and degeneration of the cerebral cortex occur independently in simian immunodeficiency virus-infected monkey.

Hui Qin Xing1, Takashi Moritoyo, Kazuyasu Mori, Kei Tadakuma, Chie Sugimoto, Fumiko Ono, Hitoshi Hayakawa, Shuji Izumo.   

Abstract

Highly active antiretroviral therapy (HAART) has been successful to reduce progression of acquired immunodeficiency syndrome (AIDS). Nevertheless, recent autopsy analysis of the brain from patients with human immunodeficiency virus (HIV)-1 infection reported same or even increasing numbers of AIDS encephalopathy. This insufficient effect of HAART for central nervous system (CNS) complication might be explained by independent pathogenetic processes in lymph node and CNS. We inoculated macaques with three Simian immunodeficiency virus (SIV) strains and investigated relationship between degree of the lymph node pathology and that of AIDS-related brain pathology. Animals infected with T-cell-tropic viruses SIVmac239 and SHIV-RT developed typical AIDS pathology in the lymph node 46 to 156 weeks after infection. The cerebral cortex of these animals showed focal or diffuse gliosis, and electron microscopic analysis demonstrated degenerative changes, such as accumulation of dense lamellar bodies in the dendrites and swelling of astrocytic processes. However, there was no evidence of microglial nodules or multinucleated giant cells in the white mater. The animals infected with macrophage-tropic SIV239env/MERT did not develop lymph node pathology of AIDS in the same or longer period of infection. The white mater of the animal, however, showed microglial nodules with multinucleated giant cells, a pathological hallmark of AIDS encephalopathy. SIV immunoreactivity was demonstrated in these giant cells as well as macrophage/microglia cells. On the other hand, there was no abnormality in the cerebral cortex. These findings suggest that there are two independent pathogenetic processes in AIDS encephalopathy: immune response against virus infected macrophage/microglial cells in the white mater without immunodeficiency and cortical degeneration caused in the late stage of AIDS.

Entities:  

Mesh:

Year:  2003        PMID: 12907395     DOI: 10.1080/13550280390218904

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  37 in total

1.  Distinct variation pattern in the env of macrophage-tropic simian immunodeficiency virus in vivo demonstrated by denaturing gradient gel electrophoresis.

Authors:  S K Dhar; K Tadakuma; K Mori
Journal:  J Virol Methods       Date:  2000-09       Impact factor: 2.014

2.  Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.

Authors:  S Czub; E Koutsilieri; S Sopper; M Czub; C Stahl-Hennig; J G Müller; V Pedersen; W Gsell; J L Heeney; M Gerlach; G Gosztonyi; P Riederer; V ter Meulen
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

Review 3.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

4.  HIV mediates a productive infection of the brain.

Authors:  C A Wiley; C L Achim; C Christopherson; Y Kidane; S Kwok; E Masliah; J Mellors; L Radhakrishnan; G Wang; V Soontornniyomkij
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

5.  Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.

Authors:  K Mori; Y Yasutomi; S Sawada; F Villinger; K Sugama; B Rosenwith; J L Heeney; K Uberla; S Yamazaki; A A Ansari; H Rübsamen-Waigmann
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Complex determinants of macrophage tropism in env of simian immunodeficiency virus.

Authors:  K Mori; D J Ringler; T Kodama; R C Desrosiers
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Clinical-neuropathologic correlation in HIV-associated dementia.

Authors:  J D Glass; S L Wesselingh; O A Selnes; J C McArthur
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

8.  Cortical dendritic pathology in human immunodeficiency virus encephalitis.

Authors:  E Masliah; N Ge; M Morey; R DeTeresa; R D Terry; C A Wiley
Journal:  Lab Invest       Date:  1992-03       Impact factor: 5.662

9.  Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS.

Authors:  R C Desrosiers; A Hansen-Moosa; K Mori; D P Bouvier; N W King; M D Daniel; D J Ringler
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

10.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  8 in total

1.  Global gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T.

Authors:  William E Wu; Assaf Tal; Ivan I Kirov; Henry Rusinek; Daniel Charytonowicz; James S Babb; Eva-Maria Ratai; R Gilberto Gonzalez; Oded Gonen
Journal:  NMR Biomed       Date:  2013-02-17       Impact factor: 4.044

2.  Lentiviral infection of rhesus macaques causes long-term injury to cortical and hippocampal projections of prostaglandin-expressing cholinergic basal forebrain neurons.

Authors:  Candan Depboylu; Eberhard Weihe; Lee E Eiden
Journal:  J Neuropathol Exp Neurol       Date:  2012-01       Impact factor: 3.685

3.  Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.

Authors:  Ei Kinai; Kensuke Komatsu; Maiko Sakamoto; Toshibumi Taniguchi; Aya Nakao; Hidetoshi Igari; Kiyonori Takada; Aki Watanabe; Ai Takahashi-Nakazato; Misao Takano; Yoshimi Kikuchi; Shinichi Oka
Journal:  J Neurovirol       Date:  2017-10-02       Impact factor: 2.643

4.  HIV-1 Tat increases BAG3 via NF-κB signaling to induce autophagy during HIV-associated neurocognitive disorder.

Authors:  Xiaoyan Wu; Huaqian Dong; Xiang Ye; Li Zhong; Tiantian Cao; Qiping Xu; Jun Wang; Yu Zhang; Jinhong Xu; Wei Wang; Qiang Wei; Ying Liu; Shuhui Wang; Yiming Shao; Huiqin Xing
Journal:  Cell Cycle       Date:  2018-08-21       Impact factor: 4.534

Review 5.  HIV-1 Tat inhibits EAAT-2 through AEG-1 upregulation in models of HIV-associated neurocognitive disorder.

Authors:  Xiang Ye; Yu Zhang; Qiping Xu; Honghua Zheng; Xiaoyan Wu; Jinhua Qiu; Zhou Zhang; Wei Wang; Yiming Shao; Hui Qin Xing
Journal:  Oncotarget       Date:  2017-06-13

6.  Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells.

Authors:  Jun Wang; Yu Zhang; Qiping Xu; Jinhua Qiu; Honghua Zheng; Xiang Ye; Yuhua Xue; Yongmei Yin; Zhou Zhang; Ying Liu; Yanling Hao; Qiang Wei; Wei Wang; Kazuyasu Mori; Shuji Izumo; Ryuji Kubota; Yiming Shao; Hui Qin Xing
Journal:  Oncotarget       Date:  2017-03-14

7.  Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis.

Authors:  Huaqian Dong; Xiang Ye; Li Zhong; Jinhong Xu; Jinhua Qiu; Jun Wang; Yiming Shao; Huiqin Xing
Journal:  Front Neurosci       Date:  2019-02-04       Impact factor: 4.677

8.  The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.

Authors:  Benjamin B Gelman; Tiansheng Chen; Joshua G Lisinicchia; Vicki M Soukup; J Russ Carmical; Jonathan M Starkey; Eliezer Masliah; Deborah L Commins; Dianne Brandt; Igor Grant; Elyse J Singer; Andrew J Levine; Jeremy Miller; Jessica M Winkler; Howard S Fox; Bruce A Luxon; Susan Morgello
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.